Title: Shuling Yang - Innovator in Anti-Tumor Medicaments
Introduction: Shuling Yang is an inventor based in Beijing, China. He has contributed to the field of anti-tumor and anti-angiogenesis medicaments. Although he currently holds no granted patents, his work is significant in the realm of medical innovations.
Latest Patent Applications: Shuling Yang has filed several patent applications, including:
1. **Conjugate Angiostatin or Its Fragment, The Method of Producing the Conjugate and Use Thereof** - This invention provides an anti-tumor or anti-angiogenesis medicament, the combination or kit containing the medicament, and the method for producing the same. The anti-tumor or anti-angiogenesis medicament contains a conjugate comprising a modifying agent and the angiostatin or its fragments, wherein the conjugate exhibits prolonged in vivo half-life as compared to an unmodified angiostatin or its fragments. The modifying agent is selected from the group consisting of macromolecular polymers, protein molecules or fragments thereof, peptides, small molecules, or chemical substances of any other forms.
2. **Conjugate Comprising Angiostatin or Its Fragment, The Method for Producing the Conjugate and Use Thereof** - Similar to the previous application, this invention also focuses on an anti-tumor or anti-angiogenesis medicament, detailing the composition and production methods for the conjugate.
Conclusion: Shuling Yang's work in the field of anti-tumor medicaments showcases his innovative approach to medical challenges. His latest patent applications reflect his commitment to advancing healthcare solutions.